OWLT Stock Analysis: Buy, Sell, or Hold?
OWLT - Owlet, Inc.
$5.55
0.15 (2.78%)
▲
5d:
-3.31%
30d:
+1.28%
90d:
-49.22%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When OWLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called OWLT this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OWLT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: OWLT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: OWLT is currently trading at $5.55, which is considered slightly high relative to its 30-day fair value range of $4.99 to $5.73. From a valuation perspective, the stock is trading at a premium (Forward PE: 83.2) compared to its historical average (68.1). At these levels, the market is pricing in 6.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OWLT is in a strong downtrend. Immediate support is located at $4.72, while resistance sits at $6.35.
Market Sentiment: OWLT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.75 (+147.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OWLT is in a strong downtrend. Immediate support is located at $4.72, while resistance sits at $6.35.
Market Sentiment: OWLT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.75 (+147.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$4.99 -
$5.73
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.2%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 147.7% below Wall St target ($13.75)
- NEUTRAL: Trading at premium valuation - market expects 6.9% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$4.99 -
$5.73
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.72
Resistance Level
$6.35
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
83.21
Wall Street Target
$13.75
(+147.7%)
Revenue Growth (YoY)
6.6%
Profit Margin
-42.9%
Valuation Premium vs History
+6.9% premium
PE vs Historical
83.2 vs 68.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.9%
(market-implied from PE analysis)
1-Year Target
$5.93
(+7%)
2-Year Target
$6.34
(+14%)
3-Year Target
$6.78
(+22%)
3-Yr Target (if PE normalizes)
(PE: 83→68)
PE COMPRESSION
$5.55
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: May 18, 2026 7:05 AM ET
Data refreshes hourly during market hours. Next update: 8:05 AM
Data refreshes hourly during market hours. Next update: 8:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OWLT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Amanda Crawford
SELL
183 shares
2026-01-20
Jonathan Harris
SELL
2311 shares
2026-01-20
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
